Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1277
https://www.valueinhealthjournal.com/article/S1098-3015(16)32643-2/fulltext
Title :
Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32643-2&doi=10.1016/j.jval.2016.09.1277
First page :
A567
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1197